We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+2.01%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$125M
AUM Growth
-$6.93M
(-5.3%)
Cap. Flow
+$7.46M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
52.89%
Holding
74
New
17
Increased
7
Reduced
11
Closed
14
Top Buys
| 1 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$23.6M |
| 2 |
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
|
+$9.19M |
| 3 |
Biogen
BIIB
|
+$4.6M |
| 4 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$3.86M |
| 5 |
Zimmer Biomet
ZBH
|
+$3.69M |
Top Sells
| 1 |
Sanofi
SNY
|
+$6.61M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$6.28M |
| 3 |
HCA Healthcare
HCA
|
+$5.27M |
| 4 |
Puma Biotechnology
PBYI
|
+$4.91M |
| 5 |
Philips
PHG
|
+$4.9M |
Sector Composition
| 1 | Healthcare | 91.84% |
| 2 | Financials | 6.43% |
| 3 | Technology | 1.41% |
| 4 | Consumer Discretionary | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $11.6M | 9.25% |
58,608
-520
| -0.9% | -$104K |
|
|
DMK
2
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $10.1M | 8.1% |
27,657
+25,907
| +1,480% | +$9.19M |
|
|
AET
3
DELISTED
Aetna Inc
AET
| $8.03M | 6.43% |
50,523
-1,477
| -3% | -$231K |
|
|
SIOX
4
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $7.7M | 6.16% |
+139,862
| New | +$23.6M |
|
5
GSK
GSK
$103B
| $6.97M | 5.58% |
137,355
+46,865
| +52% | +$2.38M |
|
|
6
Biogen
BIIB
$28.3B
| $4.87M | 3.9% |
+15,549
| New | +$4.6M |
|
7
Globus Medical
GMED
$10.3B
| $4.38M | 3.51% |
147,364
+33,964
| +30% | +$1.04M |
|
8
Medtronic
MDT
$102B
| $4.34M | 3.48% |
55,844
+25,844
| +86% | +$2.15M |
|
9
Kura Oncology
KURA
$998M
| $4.12M | 3.3% |
+275,731
| New | +$2.59M |
|
10
Rigel Pharmaceuticals
RIGL
$762M
| $3.97M | 3.18% |
156,331
+21,759
| +16% | +$529K |
|
11
Avanos Medical
AVNS
$1.17B
| $3.91M | 3.13% |
86,914
-13,685
| -14% | -$584K |
|
|
EGRX
12
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.81M | 3.05% |
+63,835
| New | +$3.86M |
|
13
Emergent Biosolutions
EBS
$387M
| $3.65M | 2.92% |
+90,268
| New | +$3.27M |
|
|
14
Zimmer Biomet
ZBH
$17.6B
| $3.63M | 2.91% |
+31,964
| New | +$3.69M |
|
|
AAAP
15
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $3.56M | 2.85% |
52,582
-55,941
| -52% | -$2.72M |
|
|
16
Puma Biotechnology
PBYI
$421M
| $3.26M | 2.61% |
27,221
-52,800
| -66% | -$4.91M |
|
|
17
Philips
PHG
$25.3B
| $2.79M | 2.24% |
89,359
-168,310
| -65% | -$4.9M |
|
18
Icon
ICLR
$13B
| $2.69M | 2.15% |
+23,604
| New | +$2.51M |
|
19
Integer Holdings
ITGR
$3.17B
| $2.62M | 2.1% |
+51,258
| New | +$2.35M |
|
20
Elevance Health
ELV
$92.7B
| $2.55M | 2.04% |
13,418
-349
| -3% | -$66.4K |
|
21
Alnylam Pharmaceuticals
ALNY
$37.6B
| $2.38M | 1.9% |
+20,225
| New | +$1.73M |
|
|
LMNX
22
DELISTED
Luminex Corp
LMNX
| $2.36M | 1.89% |
115,979
| – | – |
|
23
Vertex Pharmaceuticals
VRTX
$121B
| $2.26M | 1.81% |
+14,874
| New | +$2.24M |
|
|
24
Sanofi
SNY
$103B
| $2.25M | 1.8% |
45,099
-136,523
| -75% | -$6.61M |
|
25
UnitedHealth
UNH
$386B
| $2.24M | 1.79% |
11,430
-9,721
| -46% | -$1.88M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA